![Sophia Paspal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Sophia Paspal worked as a Director of Regulatory Affairs & Oncology at Halozyme Therapeutics, Inc. from 2015 to 2017.
Prior to that, she was an Associate Director of Regulatory Affairs & Neurology at Dart NeuroScience LLC in 2014-2015.
Dr. Paspal also served as the Chief Development Officer at Xynomic Pharmaceuticals Holdings, Inc. Dr. Paspal received her undergraduate and doctorate degrees from the University of Minnesota.
Ehemalige bekannte Positionen von Sophia Paspal
| Unternehmen | Position | Ende |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2017 |
Dart NeuroScience LLC
 Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory | Corporate Officer/Principal | 01.01.2015 |
| XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sophia Paspal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dart NeuroScience LLC
Dart NeuroScience LLC Pharmaceuticals: MajorHealth Technology Develops drugs to improve memory | Health Technology |
Xynomic Pharmaceuticals Holdings, Inc.
 Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and supplies oncology drugs | Health Technology |
